Published in Br J Ophthalmol on August 07, 2012
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev (2014) 1.76
Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2014) 0.86
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology (2012) 4.70
A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet (2006) 3.96
Clinical classification of age-related macular degeneration. Ophthalmology (2013) 2.92
The association between complement component 2/complement factor B polymorphisms and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol (2012) 2.87
Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol (2006) 2.82
Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study. Ophthalmology (2011) 2.47
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology (2007) 2.46
Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol (2013) 2.44
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol (2010) 2.32
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet (2011) 1.98
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database Syst Rev (2014) 1.95
Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol (2005) 1.95
Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study. Arch Ophthalmol (2007) 1.94
Classification of fundus autofluorescence patterns in early age-related macular disease. Invest Ophthalmol Vis Sci (2005) 1.76
Age related macular degeneration. BMJ (2003) 1.72
Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments. Am J Ophthalmol (2010) 1.71
New treatments for neovascular acute macular degeneration. BMJ (2007) 1.69
Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol (2002) 1.67
Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol (2011) 1.42
Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. EuroIntervention (2014) 1.41
Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. N Engl J Med (2017) 1.40
Bevacizumab for the treatment of neovascular age related macular degeneration. BMJ (2010) 1.40
Artifacts in automatic retinal segmentation using different optical coherence tomography instruments. Retina (2010) 1.32
Spectral-domain OCT evaluation of Nd:YAG laser treatment for Valsalva retinopathy. Graefes Arch Clin Exp Ophthalmol (2009) 1.31
Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr (2008) 1.29
Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. PLoS Med (2007) 1.27
Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology (2007) 1.26
Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol (2008) 1.21
Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study. Pharmacoeconomics (2008) 1.20
Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol (2011) 1.19
Prevalence of cataract in an older population in India: the India study of age-related eye disease. Ophthalmology (2011) 1.19
Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat (2011) 1.17
Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci (2008) 1.16
Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology (2012) 1.16
Visual impairment and quality of life in the older European population, the EUREYE study. Acta Ophthalmol (2009) 1.14
Management of retinal vein occlusion--consensus document. Ophthalmologica (2011) 1.14
Enhanced depth imaging optical coherence tomography features of choroidal osteoma. Retina (2014) 1.12
Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype. Int J Epidemiol (2012) 1.12
Gene expression profiling in autoimmune noninfectious uveitis disease. J Immunol (2008) 1.12
Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN Study. Ophthalmology (2013) 1.11
Evidence for association of endothelial nitric oxide synthase gene in subjects with glaucoma and a history of migraine. Invest Ophthalmol Vis Sci (2005) 1.10
Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2013) 1.10
Psychophysical function in age-related maculopathy. Surv Ophthalmol (2009) 1.09
Maculopathy resolution after surgery for an optic disc pit. Ophthalmology (2013) 1.08
EPHA2 polymorphisms and age-related cataract in India. PLoS One (2012) 1.06
Serous macular detachment in Waldenström macroglobulinemia: a report of 4 cases. Am J Ophthalmol (2013) 1.06
Optical coherence tomography in eyes with vitreomacular traction. Ophthalmology (2013) 1.06
Prevalence of early and late age-related macular degeneration in India: the INDEYE study. Invest Ophthalmol Vis Sci (2009) 1.05
Methods for a population-based study of the prevalence of and risk factors for age-related maculopathy and macular degeneration in elderly European populations: the EUREYE study. Ophthalmic Epidemiol (2004) 1.05
Bimodal spatial distribution of macular pigment: evidence of a gender relationship. J Opt Soc Am A Opt Image Sci Vis (2006) 1.05
The dynamic healing process of idiopathic macular holes after surgical repair: a spectral-domain optical coherence tomography study. Invest Ophthalmol Vis Sci (2011) 1.05
The natural history of lamellar macular holes: a spectral domain optical coherence tomography study. Graefes Arch Clin Exp Ophthalmol (2012) 1.05
Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 1.04
Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritis. Arthritis Rheumatol (2014) 1.03
Blood levels of vitamin C, carotenoids and retinol are inversely associated with cataract in a North Indian population. Invest Ophthalmol Vis Sci (2008) 1.03
Prevalence of early and late age-related macular degeneration in a rural population in northern India: the INDEYE feasibility study. Invest Ophthalmol Vis Sci (2007) 1.03
AMD and micronutrient antioxidants. Curr Eye Res (2004) 1.02
High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis. J Autoimmun (2008) 1.01
Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. Ophthalmology (2012) 1.00
Retinal angiomatous proliferation: natural history and progression of visual loss. Retina (2009) 0.99
Spectral-domain optical coherence tomography as an indicator of fluorescein angiography leakage from choroidal neovascularization. Invest Ophthalmol Vis Sci (2011) 0.99
Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb. J Drug Deliv (2012) 0.98
Fundus autofluorescence in age-related macular degeneration: an epiphenomenon? Invest Ophthalmol Vis Sci (2006) 0.97
DNA-based eye colour prediction across Europe with the IrisPlex system. Forensic Sci Int Genet (2011) 0.94
Prevalence of lens opacities in North India: the INDEYE feasibility study. Invest Ophthalmol Vis Sci (2007) 0.93
Grading of age-related maculopathy for epidemiological studies: is digital imaging as good as 35-mm film? Ophthalmology (2003) 0.93
Ocular hypotony secondary to spontaneously ruptured sclera in choroidal coloboma. Arch Ophthalmol (2004) 0.93
Associations between aspirin use and aging macula disorder: the European Eye Study. Ophthalmology (2011) 0.93
Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis. Ophthalmology (2009) 0.93
Increasing use of a new health technology during the wait for NICE guidance: findings from the third national tracker survey of photodynamic therapy. J Public Health (Oxf) (2004) 0.92
Aligning scan locations from consecutive spectral-domain optical coherence tomography examinations: a comparison among different strategies. Invest Ophthalmol Vis Sci (2012) 0.92
Distortion maps from preferential hyperacuity perimetry are helpful in monitoring functional response to Lucentis therapy. Retina (2009) 0.92
A 12-week, randomized, double-masked study of fixed combination latanoprost/timolol versus latanoprost or timolol monotherapy. Eur J Ophthalmol (2011) 0.91
Prevalence and risk factors for vitamin C deficiency in north and south India: a two centre population based study in people aged 60 years and over. PLoS One (2011) 0.91
Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study. Ophthalmology (2013) 0.91
Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study. Arch Ophthalmol (2010) 0.90
Bilateral juvenile choroidal neovascularization associated with Best's vitelliform dystrophy: observation versus photodynamic therapy. J Pediatr Ophthalmol Strabismus (2010) 0.90
Fundus autofluorescence findings in a mouse model of retinal detachment. Invest Ophthalmol Vis Sci (2012) 0.90
Argon laser trabeculoplasty for intractable glaucoma following intravitreal triamcinolone. Arch Ophthalmol (2006) 0.89
Evaluation of prostaglandin analogue effects on corneal keratocyte density using scanning laser confocal microscopy. J Glaucoma (2010) 0.89
Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype. Invest Ophthalmol Vis Sci (2005) 0.88
Inverse association of vitamin C with cataract in older people in India. Ophthalmology (2011) 0.88
Choroidal granulomas visualized by enhanced depth imaging optical coherence tomography. Retina (2015) 0.88
Complement component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort. Mol Vis (2010) 0.87
Dopaminergic polymorphisms associated with time-on-task declines and fatigue in the Psychomotor Vigilance Test. PLoS One (2012) 0.87
Small RNAs from plants, bacteria and fungi within the order Hypocreales are ubiquitous in human plasma. BMC Genomics (2014) 0.86
Economic cost of age-related macular degeneration: a review of recent research. Drugs Aging (2006) 0.86
Accuracy of the Heidelberg Spectralis in the alignment between near-infrared image and tomographic scan in a model eye: a multicenter study. Am J Ophthalmol (2013) 0.86
Optic nerve head tubercular granuloma successfully treated with anti-VEGF intravitreal injections in addition to systemic therapy. Eur J Ophthalmol (2014) 0.85
An ecological correlation study of late age-related macular degeneration and the complement factor H Y402H polymorphism. Invest Ophthalmol Vis Sci (2009) 0.85
Common spatio-temporal pattern for single-trial detection of event-related potential in rapid serial visual presentation triage. IEEE Trans Biomed Eng (2011) 0.85
Transnasal endoscopic dacryocystorhinostomy for the treatment of lacrimal pathway stenoses in pediatric patients. Int J Pediatr Otorhinolaryngol (2003) 0.84
Discriminative analysis of brain functional connectivity patterns for mental fatigue classification. Ann Biomed Eng (2014) 0.84
A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models. J Ocul Pharmacol Ther (2012) 0.84
Formal and informal care utilisation amongst elderly persons with visual impairment. Br J Ophthalmol (2007) 0.84
Repeatability and reproducibility of retinal thickness measurements with spectral-domain optical coherence tomography using different scan parameters. Retina (2012) 0.84
A case-control study of drug risk factors for age-related macular degeneration. Ophthalmology (2007) 0.83
Reproducibility of fluorescein and indocyanine green angiographic assessment for RAP diagnosis: a multicenter study. Eur J Ophthalmol (2012) 0.83
Functional and morphologic benefits in early detection of neovascular age-related macular degeneration using the preferential hyperacuity perimeter. Retina (2011) 0.83